RISE Life Science Corp.

Recent News

  • Britannia Enters into Definitive Agreement with Rise Life Science to "Go Public" via Reverse Takeover of Rise Life Science

    Toronto, Ontario--(Newsfile Corp. - May 3, 2021) - Britannia Bud Canada Holdings Inc. (d/b/a Britannia Life Sciences) ("Britannia") and RISE Life Science Corp. (CSE: RLSC) ("RISE") are pleased to announce that Britannia, RISE and 2830026 Ontario Inc. ("RISE Subco"), a wholly-owned subsidiary of RISE, have entered into a business combination agreement dated April 30, 2021 (the "Definitive Agreement") in respect of their previously-announced transaction. Completion of this transaction will result in a reverse takeover of RISE (the "RTO") and...

    2021-05-03 8:47 AM EDT
  • RISE Life Science Corp. Announces Closing of Non-Brokered Financing

    Toronto, Ontario--(Newsfile Corp. - April 15, 2021) -  RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has closed the final tranche of its previously announced non-brokered private placement offering of subscription receipts for gross proceeds of USD$621,000 through this issuance of 621 subscription receipts (the "Subscription Receipts") at a price of USD$1,000 per Subscription Receipt (the "Offering"). The gross proceeds of the Offering (the "Escrowed Proceeds") are being held in escrow on behalf of the...

    2021-04-15 5:31 PM EDT
  • RISE Life Science Corp. Announces Closing of Non-Brokered Financing

    Toronto, Ontario--(Newsfile Corp. - March 5, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has closed a non-brokered private placement offering of gross proceeds of subscription receipts for gross proceeds of USD$710,000 through this issuance of 710 subscription receipts (the "Subscription Receipts") at a price of USD$1,000 per Subscription Receipt (the "Offering"). The gross proceeds of the Offering (the "Escrowed Proceeds") are being held in escrow on behalf of the subscribers of the...

    2021-03-05 8:00 AM EST
  • RISE Life Science Corp. Announces Proposed Transaction with Britannia Life Sciences

    Toronto, Ontario--(Newsfile Corp. - January 22, 2021) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has entered into an agreement with Britannia Bud Canada Holdings Inc., dba Britannia Life Sciences ("Britannia"), dated January 21, 2021 to amend and confirm a letter of intent previously agreed to by the parties (the "Agreement"), pursuant to which RISE and Britannia have agreed to complete a business combination transaction (the "Proposed Transaction"). If completed, the Proposed Transaction...

    2021-01-22 10:50 AM EST
  • RISE Life Science Advises Extension for Filing First Quarter Statements

    Toronto, Ontario--(Newsfile Corp. - April 27, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or "Company") announces that it will not be in a position to file its interim financial statements for the fiscal quarter ended February 29, 2020 and the related management's discussion and analysis, as required by Part 4 and Part 5 of National Instrument 51-102: Continuous Disclosure Obligations (collectively, the "Q1 Filings") by the filing deadline of April 29, 2020.This news release is being issued in...

    2020-04-27 9:00 PM EDT
  • RISE Life Science Corp. Announces Revised Private Placement Structure Led by Canaccord Genuity Corp.

    Toronto, Ontario--(Newsfile Corp. - April 21, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announced on April 13, 2020 that it has entered into a binding letter agreement (the "Agreement") dated April 13, 2020 with HydRx Farms Ltd. o/a Scientus Pharma ("Scientus") to complete a business combination of RISE and Scientus (the "Transaction"). If completed, the Transaction will constitute a "fundamental change" of RISE pursuant to the policies of the Canadian Securities Exchange (the...

    2020-04-21 1:00 PM EDT
  • RISE Life Science Corp. Announces Proposed Transaction with Scientus Pharma

    Toronto, Ontario--(Newsfile Corp. - April 13, 2020) -  RISE Life Science Corp. (CSE: RLSC) ("RISE" or the "Company") announces that it has entered into a binding letter agreement (the "Agreement") dated April 13, 2020 with HydRx Farms Ltd. o/a Scientus Pharma ("Scientus") to complete a business combination of RISE and Scientus (the "Transaction"). If completed, the Transaction will constitute a "fundamental change" of RISE pursuant to the policies of the Canadian Securities Exchange (the "CSE"). The resulting issuer...

    2020-04-13 9:00 PM EDT
  • RISE Life Science Advises Extension for Filing Annual Statements

    Toronto, Ontario--(Newsfile Corp. - April 1, 2020) - RISE Life Science Corp. (CSE: RLSC) ("RISE" or "Company") announces that it will not be in a position to file its audited annual financial statements for the fiscal year ended November 30, 2019 and the related management's discussion and analysis, as required by Part 4 and Part 5 of National Instrument 51-102: Continuous Disclosure Obligations (collectively, the "Annual Filings") by the filing deadline of March 30, 2020.This news release is being...

    2020-04-01 8:35 AM EDT